An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy
Study sponsor: Scholar Rock, Inc.
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2021-01-19Actual
Enrollment · participants58Actual
Source updated2024-12-02Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.